Discover

BDX
Becton, Dickinson and Company
192.00
400 x 180.00
300 x 192.50
bid
ask
+
4.38
2.33%
350 @ 07:58 PM
191.99 -0.01 (0.01%)
Ytd25.84%
1y24.21%
186.95
day range
192.29
138.67
52 week range
192.00
Open188.02Prev Close187.62Low186.95High192.29Mkt Cap52.30B
Vol1.79MAvg Vol2.27MEPS5.91P/E32.49Forward P/E14.44
Beta0.26Short Ratio5.63Inst. Own99.61%Dividend4.20Div Yield2.24
Ex Div Date09-09Earning11-0550-d Avg160.52200-d Avg157.391yr Est194.42
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-052026-094.06N/AN/AN/A
2026-08-062026-063.143.230.092.87%
2026-05-072026-032.782.90.124.32%
2026-02-092025-122.212.910.731.67%
2025-11-062025-093.923.960.041.02%
2025-08-072025-063.43.680.288.24%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-13RBC CapitalUpgradeSector PerformSector Perform
2026-08-07CitigroupUpgradeBuyBuy
2026-08-07RBC CapitalUpgradeSector PerformSector Perform
2026-08-07Piper SandlerUpgradeNeutralNeutral
2026-08-07Wells FargoUpgradeEqual-WeightEqual-Weight
2026-08-05TD CowenUpgradeHoldHold
Profile
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Holder
DateNameRelationQuantityDescription
2025-11-25DELOREFICE CHRISTOPHERChief Financial Officer22.98KStock Award(Grant)
2026-07-26FELD MICHAELOfficer20.93KSale
2025-09-09FRASER CLAIREDirector22.23KSale
2026-08-10GOETTE ROLANDOfficer16.64KSale
2026-01-26JONES CHRISTOPHER IAN MONTAGUEDirector24.30KStock Award(Grant)
2026-06-30MUHSIN BILALOfficer41.36KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.24.59M4.72B8.93%
2026-06-29Vanguard Capital Management LLC17.99M3.45B6.53%
2026-06-29State Street Corporation15.00M2.88B5.44%
2026-06-29Vanguard Portfolio Management LLC14.97M2.87B5.43%
2026-06-29First Eagle Investment Management, LLC13.82M2.65B5.01%
2026-06-29Invesco Ltd.8.90M1.71B3.23%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund9.04M1.74B3.28%
2026-04-29First Eagle Funds-First Eagle Global Fund8.06M1.55B2.92%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund7.24M1.39B2.63%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund6.15M1.18B2.23%
2026-03-30T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App5.80M1.11B2.10%
2026-06-29iShares Trust-iShares Core S&P 500 ETF3.80M729.86M1.38%
Dividend
DividendDate
1.052026-09-09
1.052026-06-09
1.052026-03-10
1.052025-12-08
1.042025-09-08
1.042025-06-09
Split
SplitDate
1025 : 10002022-04-01
2 : 11998-08-21
2 : 11996-08-16
2 : 11993-03-01
2 : 11986-03-03